Cipla Faces Share Price Plunge
Cipla, a leading pharmaceutical company, witnessed a sharp decline in its share prices by over 8 percent following scrutiny from the US health regulator regarding manufacturing irregularities at its Pithampur facility in Madhya Pradesh. The market cap of the company also took a hit, decreasing by a significant margin. Share Price Drop The stock of […]
Read More